Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenglong Zhao

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
Angewandte Chemie (International Ed. in English)|October 18, 2019
High-Entropy Layered Oxide Cathodes for Sodium-Ion BatteriesChenglong Zhao, Feixiang Ding, Yaxiang Lu, et al.
Frontiers in Oncology|July 18, 2022
Whole-Exome Sequencing Uncovers Specific Genetic Variation Difference Based on Different Modes of Drug Resistance in Small Cell Lung CancerNing Tang, Zhenzhen Li, Xiao Han, et al.
Frontiers in Immunology|July 8, 2025
The safety and effectiveness of sintilimab versus camrelizumab, both plus targeted drugs, in advanced hepatocellular carcinomaChenglong Zhao, Qiongni Zhu, Xiaoyan Qian, et al.
Gene|May 5, 2024
Identification of cotton PIP5K genes and role of GhPIP5K9a in primary root developmentKaikai Qiao, Jiaoyan Lv, Juxin Hao, et al.
Peerj|December 12, 2019
Different distant metastasis patterns based on tumor size could be found in extensive-stage small cell lung cancer patients: a large, population-based SEER studyJia Li, Feng Liu, Haining Yu, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|December 13, 2023
Variational Adversarial Defense: A Bayes Perspective for Adversarial TrainingChenglong Zhao, Shibin Mei, Bingbing Ni, et al.
Plos One|September 26, 2025
Multi-carrier information hiding based on projection-driven vertex embedding in 3D modelsYuefa Ou, Jie Ke, Mingkun Yang, et al.
Frontiers in Immunology|July 12, 2021
A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving AtezolizumabJiamao Lin, Xiaohui Wang, Chenyue Zhang, et al.
Cancer Medicine|July 31, 2021
A clinical variable-based nomogram could predict the survival for advanced NSCLC patients receiving second-line atezolizumabXiaoling Shang, Jianxiang Shi, Xiaohui Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|February 28, 2021
Survival analysis for non-squamous NSCLC patients harbored STK11 or KEAP1 mutation receiving atezolizumabXiaoling Shang, Zhenxiang Li, Jian Sun, et al.
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Angewandte Chemie (International Ed. in English)|October 18, 2019
High-Entropy Layered Oxide Cathodes for Sodium-Ion BatteriesChenglong Zhao, Feixiang Ding, Yaxiang Lu, et al.
Frontiers in Oncology|July 18, 2022
Whole-Exome Sequencing Uncovers Specific Genetic Variation Difference Based on Different Modes of Drug Resistance in Small Cell Lung CancerNing Tang, Zhenzhen Li, Xiao Han, et al.
Frontiers in Immunology|July 8, 2025
The safety and effectiveness of sintilimab versus camrelizumab, both plus targeted drugs, in advanced hepatocellular carcinomaChenglong Zhao, Qiongni Zhu, Xiaoyan Qian, et al.
Gene|May 5, 2024
Identification of cotton PIP5K genes and role of GhPIP5K9a in primary root developmentKaikai Qiao, Jiaoyan Lv, Juxin Hao, et al.
Peerj|December 12, 2019
Different distant metastasis patterns based on tumor size could be found in extensive-stage small cell lung cancer patients: a large, population-based SEER studyJia Li, Feng Liu, Haining Yu, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|December 13, 2023
Variational Adversarial Defense: A Bayes Perspective for Adversarial TrainingChenglong Zhao, Shibin Mei, Bingbing Ni, et al.
Plos One|September 26, 2025
Multi-carrier information hiding based on projection-driven vertex embedding in 3D modelsYuefa Ou, Jie Ke, Mingkun Yang, et al.
Frontiers in Immunology|July 12, 2021
A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving AtezolizumabJiamao Lin, Xiaohui Wang, Chenyue Zhang, et al.
Cancer Medicine|July 31, 2021
A clinical variable-based nomogram could predict the survival for advanced NSCLC patients receiving second-line atezolizumabXiaoling Shang, Jianxiang Shi, Xiaohui Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|February 28, 2021
Survival analysis for non-squamous NSCLC patients harbored STK11 or KEAP1 mutation receiving atezolizumabXiaoling Shang, Zhenxiang Li, Jian Sun, et al.
Pageof 17